Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Beta 4 for diabetic corneal wounds after vitrectomy
NCT00598871Phase 2Terminated
- Sponsor
- ReGenTree
- Start
- Dec 2007
- Primary completion
- Feb 2009
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of thymosin beta-4 in corneal wound, sponsored by ReGenTree. Started Dec 2007; status: terminated.
02
Drugs
thymosin beta-4
03
Conditions
corneal wound
Beyond the preview
Go deeper on NCT00598871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598871.